Services

Senior scientific judgment, applied where your program needs it.

Consulting

  1. 01

    Small-molecule bioanalysis

    End-to-end support for exploratory and regulated studies: method strategy, LC-MS/MS development and validation, sample-analysis oversight, and report review. Method experience spans small molecules, peptides, proteins, and polymers.

  2. 02

    Nonclinical DMPK

    In vivo and in vitro study design, protocol development, data analysis, and interpretation for metabolite profiling, metabolite identification, DDI, and PK studies that support go/no-go decisions.

  3. 03

    Regulatory strategy

    Study design and submission planning for IND and NDA, including preparation for regulatory interactions.

  4. 04

    Outsourcing and CRO oversight

    CRO selection, study placement, and oversight across multiple CROs at once, including assay troubleshooting and root-cause investigation, drawing on 10+ years on each side of the sponsor–CRO relationship.

Specialized services

  1. 05

    PK and TK analysis and reporting

    Noncompartmental analysis (NCA) of pharmacokinetic (PK) and toxicokinetic (TK) data, including exposure, dose proportionality, accumulation, and sex comparisons, with audit-ready PK/TK reports and report sections for nonclinical and clinical studies.

  2. 06

    Technical writing

    SOPs, protocols, study reports, and submission documents, plus automated PK and bioanalysis reporting.

  3. 07

    Laboratory operations

    Set up new bioanalysis and DMPK laboratories, or streamline and automate the routine workflows in existing ones.

  4. 08

    Training and coaching

    Hands-on HPLC and LC-MS/MS training, method-development and troubleshooting coaching, and instruction in writing and editing English scientific reports.

Areas of focus

  • Discovery PK
  • ADME
  • Metabolite identification and MIST
  • Drug–drug interactions (DDI)
  • PK/PD interpretation
  • Plasma protein binding and RBC partitioning
  • Fit-for-purpose bioanalysis
  • Chiral and unstable analytes
  • Imaging mass spectrometry
  • Method validation (ICH M10)

Approach

A clear path from question to decision.

Engagements are scoped to your stage, whether that is a single report review or ongoing program support across CRO partners.

  1. 01

    Review

    Start with your data, reports, and timelines to define the real question.

  2. 02

    Design

    Study plans, decision trees, and CRO specifications fit to your stage and budget.

  3. 03

    Oversee

    Method, sample-analysis, and report review alongside your CRO partners.

  4. 04

    Decide

    Decision-ready interpretation and documentation built for regulatory submission.

Have a study or program decision ahead?

Discuss a study